Victoria S Humphrey, Adewunmi Adelaja, Balaji Jothishankar, Ramone F Williams
{"title":"Pigmented Basal Cell Carcinoma in Skin of Color: A Systematic Review of the Literature.","authors":"Victoria S Humphrey, Adewunmi Adelaja, Balaji Jothishankar, Ramone F Williams","doi":"10.36849/JDD.9342","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Though basal cell carcinoma (BCC) is most often studied in Fitzpatrick Skin Types (FST) I-III, BCC in skin of color (SOC) is characterized by unique clinical features and a propensity toward pigmentation. While cutaneous malignancy occurs with decreased frequency in FST IV - VI, the diagnosis is generally associated with disproportionately increased morbidity and mortality. Accordingly, it is increasingly vital for dermatologists to recognize clinical presentations of skin cancer in individuals with SOC to improve outcomes and mitigate gaps in care.</p><p><strong>Objective: </strong>We systematically reviewed the literature regarding pigmented basal cell carcinoma (pBCC) in individuals with SOC.</p><p><strong>Methods and materials: </strong>The keywords “pigmented basal cell carcinoma” and “pBCC” were independently combined with “Asian,” “Black,” “Hispanic,” “Latinx,” “skin of color,” and “SOC” to perform a PubMed/MEDLINE search.</p><p><strong>Results: </strong>Based on the selected search terms, 26 unique articles were identified. Of these, 16 articles met the inclusion criteria for full-text screening.</p><p><strong>Conclusion: </strong>Pigmented BCC is more common in those with SOC and can be clinically challenging to diagnose. As evidence suggests that pBCC confers a favorable prognosis, efforts to standardize reporting and formalize sub-classification should be considered. Furthermore, as the existing literature is primarily retrospective with small sample sizes, larger prospective studies would be valuable additions to the literature and aid in shedding light on disparate outcomes associated with cutaneous malignancy in skin of color.</p>","PeriodicalId":15566,"journal":{"name":"Journal of Drugs in Dermatology","volume":"25 7","pages":"605-610"},"PeriodicalIF":2.2000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drugs in Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.36849/JDD.9342","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Though basal cell carcinoma (BCC) is most often studied in Fitzpatrick Skin Types (FST) I-III, BCC in skin of color (SOC) is characterized by unique clinical features and a propensity toward pigmentation. While cutaneous malignancy occurs with decreased frequency in FST IV - VI, the diagnosis is generally associated with disproportionately increased morbidity and mortality. Accordingly, it is increasingly vital for dermatologists to recognize clinical presentations of skin cancer in individuals with SOC to improve outcomes and mitigate gaps in care.
Objective: We systematically reviewed the literature regarding pigmented basal cell carcinoma (pBCC) in individuals with SOC.
Methods and materials: The keywords “pigmented basal cell carcinoma” and “pBCC” were independently combined with “Asian,” “Black,” “Hispanic,” “Latinx,” “skin of color,” and “SOC” to perform a PubMed/MEDLINE search.
Results: Based on the selected search terms, 26 unique articles were identified. Of these, 16 articles met the inclusion criteria for full-text screening.
Conclusion: Pigmented BCC is more common in those with SOC and can be clinically challenging to diagnose. As evidence suggests that pBCC confers a favorable prognosis, efforts to standardize reporting and formalize sub-classification should be considered. Furthermore, as the existing literature is primarily retrospective with small sample sizes, larger prospective studies would be valuable additions to the literature and aid in shedding light on disparate outcomes associated with cutaneous malignancy in skin of color.
期刊介绍:
The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology.
We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality.
Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.